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Background: Type 2 DM patients (P) who are carriers of the C allele of the rs956115 marker of the Insulin Receptor Sustrate-1 (IRS-1) gene have 
a hyperreactive platelet phenotype and increased risk of major adverse cadiovascular events (MACE). However, if an intensive Glycemic Control (IGC) 
modulates platelet function in C carriers of rs956115 marker has not been explored. 
Methods: The CHIPS (Control de la HIperglucemia y Función Plaquetaria en Pacientes con Síndrome Coronario Agudo) study was a prospective, 
randomized trial evaluating the effects of IGC (glucose 80-120 mg/dL) compared to conventional glycemic control (CGC) (glucose ≤180mg/dL) on 
platelet reactivity in ACS P with hyperglycemia. Platelet aggregation was assessed by light transmittance aggregometry stimulating with ADP (5 and 
20μM), collagen 6μg/ml, epinephrine 20μM and TRAP 25μS. The platelet P2Y12 reactivity index (PRI) and surface expression of activated GPIIb/IIIa 
and P-selectin were assased by flow cytometry. Genomic deoxyribonucleic acid was extracted from peripheral-blood leucocytes with standard salting-
out procedures. The selection of the tag SNPs of IRS-1 gene was performed with GEVALT 2.0 software. 
Results: The rs956115 polymorphism was determined in 115 P randomized to an IGC (n=59) or to a CGC (n=56). A total of 24 P were carriers of 
the C allele (IGC; n=13 and CGC; n=11).There were no differences between groups in baseline characteristics or MACE. P carriers of the C alllele 
and asigned to IGC had a reduced platelet reactivity compared with P asigned to CGC: ADP20μM (47.5±16.3% vs 63.1±23.5%; p=0.06); ADP5μM 
(29.8±14.2% vs 49.6±28.7% ; p=0.04); collagen (33.4±21.6% vs 64.1 ± 22.2%;p=0.01); epinephrine (32.4±15.9%vs 48.7±29.1%; p=0.06); 
TRAP (61.3±12.6 vs 70.2±19.2%; p=0.11); IRP (43.6±19.6% vs 55.3±19,2%; p=0.09); GPIIb/IIIa (41.0±26.4% vs 48.7±19.3%; p=0.13; P-selectin 
(44.8±21.1% vs 58.0±23.6%; p=0.05). We didn´t observe any differences in platelet reactivity in P non-carriers of the allele C. 
Conclusions: In hyperglucemic P suffering an ACS and carriers of the allele C, an IGC results in reduced platelet reactivity compared with a CGC. 
This beneficial effect is not observedin P non-carriers of the allele C.
